These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27160971)

  • 1. MELD-based allocation of deceased donor livers: is equality possible?
    Neuberger J
    Transpl Int; 2016 Aug; 29(8):880-2. PubMed ID: 27160971
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
    Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA
    Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same policy, different impact: Center-level effects of share 35 liver allocation.
    Murken DR; Peng AW; Aufhauser DD; Abt PL; Goldberg DS; Levine MH
    Liver Transpl; 2017 Jun; 23(6):741-750. PubMed ID: 28407441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the meld system provide equal access to liver transplantation for patients with different ABO blood groups?
    IJtsma AJ; van der Hilst CS; Nijkamp DM; Bottema JT; Fidler V; Porte RJ; Slooff MJ
    Transpl Int; 2016 Aug; 29(8):883-9. PubMed ID: 26987934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-Nonidentical Liver Transplantation in the United States.
    Lai JC; Roberts JP
    Am J Transplant; 2016 Aug; 16(8):2430-6. PubMed ID: 26932134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of paired donation to live donor liver transplantation.
    Segev DL; Montgomery RA
    Liver Transpl; 2010 Apr; 16(4):423-5. PubMed ID: 20373453
    [No Abstract]   [Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study.
    Goet JC; Hansen BE; Tieleman M; van Hoek B; van den Berg AP; Polak WG; Dubbeld J; Porte RJ; Konijn-Janssen C; de Man RA; Metselaar HJ; de Vries AC
    Transpl Int; 2018 Jun; 31(6):590-599. PubMed ID: 29150966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising recent data on ABO incompatible liver transplantation: restrictions may apply.
    Pratschke J; Tullius SG
    Transpl Int; 2007 Aug; 20(8):647-8. PubMed ID: 17610466
    [No Abstract]   [Full Text] [Related]  

  • 12. Candidate selection and organ allocation in liver transplantation.
    Dawwas MF; Gimson AE
    Semin Liver Dis; 2009 Feb; 29(1):40-52. PubMed ID: 19235658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expedited liver allocation in the United States: a critical analysis.
    Kinkhabwala M; Lindower J; Reinus JF; Principe AL; Gaglio PJ
    Liver Transpl; 2013 Oct; 19(10):1159-65. PubMed ID: 23696516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to liver transplantation: can we do a better job?
    Cacciarelli TV
    Liver Transpl; 2005 Nov; 11(11):1318-9. PubMed ID: 16237694
    [No Abstract]   [Full Text] [Related]  

  • 15. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The system is broken--it needs to be fixed.
    Semple NM
    Clin Transpl; 1996; ():335-7. PubMed ID: 9312266
    [No Abstract]   [Full Text] [Related]  

  • 17. Do we need to MEND the MELD?
    Gish RG
    Liver Transpl; 2007 Apr; 13(4):486-7. PubMed ID: 17394144
    [No Abstract]   [Full Text] [Related]  

  • 18. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation from non-heart-beating donors: current status and future prospects.
    Reddy S; Zilvetti M; Brockmann J; McLaren A; Friend P
    Liver Transpl; 2004 Oct; 10(10):1223-32. PubMed ID: 15376341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK; Massie AB; Luo X; Wickliffe CE; Gentry SE; Cameron AM; Segev DL
    Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.